Viking Therapeutics Inc (VKTX) — Strategic Asset Allocation Index
Viking Therapeutics Inc (VKTX) has a Strategic Asset Allocation Index of 1.0% as of March 2023. Strategic assets (PP&E of $1.35 Million plus long-term investments of $-) total $1.35 Million, measured against net assets of $134.06 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Viking Therapeutics Inc Strategic Asset Allocation Index (2015–2022)
This chart shows how Viking Therapeutics Inc's Strategic Asset Allocation Index has evolved across 7 annual periods from 2015 to 2022. As of March 2023, the index stands at 1.0%, representing strategic assets of $1.35 Million against net assets of $134.06 Million USD. Explore Viking Therapeutics Inc (VKTX) cash conversion ratio to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Viking Therapeutics Inc (2015–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Viking Therapeutics Inc from 2015 to 2022, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see VKTX stock market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 1.0% | $1.42 Million | $1.42 Million | $- | $145.32 Million | ▲ +1.0 pp |
| 2021 | 0.0% | $25.00K | $25.00K | $- | $201.88 Million | ▼ -0.1 pp |
| 2020 | 0.1% | $321.00K | $321.00K | $- | $244.34 Million | ▼ -0.1 pp |
| 2019 | 0.2% | $598.00K | $598.00K | $- | $277.12 Million | ▲ +0.2 pp |
| 2017 | 0.0% | $0.00 | $0.00 | $- | $13.46 Million | ▲ +0.0 pp |
| 2016 | 0.0% | $0.00 | $0.00 | $- | $8.04 Million | ▲ +0.0 pp |
| 2015 | 0.0% | $0.00 | $0.00 | $- | $8.72 Million | — |